Back to search
Radioactive Iodine-refractory Differentiated Thyroid Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Radioactive Iodine-refractory Differentiated Thyroid Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Radioactive Iodine-refractory Differentiated Thyroid Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
CABOTHYROID is a prospective, exploratory, biomarker-focused, phase II, single-arm, non-randomized, non-blinded, investigator-initiated study of cabozantinib in…
This is a multicentric prospective non-randomized phase II trial, with two independent arms: one for patients with RAS mutation and one for patients with BRAFV6…